Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models
Cells · 2025
DOI: 10.3390/cells14040292 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Cátia D Correia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal. Hauptthemen laut MEDLINE: Organoids, Glioblastoma, Brain Neoplasms, Brain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, PhD fellowship.
Abstract (Originalsprache)
Glioblastoma (GBM) is a relatively rare but highly aggressive form of brain cancer characterized by rapid growth, invasiveness, and resistance to standard therapies. Despite significant progress in understanding its molecular and cellular mechanisms, GBM remains one of the most challenging cancers to treat due to its high heterogeneity and complex tumor microenvironment. To address these obstacles, researchers have employed a range of models, including in vitro cell cultures and in vivo animal models, but these often fail to replicate the complexity of GBM. As a result, there has been a growing focus on refining these models by incorporating human-origin cells, along with advanced genetic techniques and stem cell-based bioengineering approaches. In this context, a variety of GBM models based on brain organoids were developed and confirmed to be clinically relevant and are contributing to the advancement of GBM research at the preclinical level. This review explores the preparation and use of brain organoid-based models to deepen our understanding of GBM biology and to explore novel therapeutic approaches. These innovative models hold significant promise for improving our ability to study this deadly cancer and for advancing the development of more effective treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
- Faculdade de Medicina e Ciências Biomédicas (FMCB), Universidade do Algarve (UAlg), Campus de Gambelas, 8005-139 Faro, Portugal.
- Faculdade de Ciências e Tecnologia (FCT), Universidade dos Açores (UAc), 9500-321 Ponta Delgada, Portugal.
- Escola Superior de Saúde (ESS), Universidade do Algarve (UAlg), Campus de Gambelas, 8005-139 Faro, Portugal.
ORCID-Profile: Alexandra Matos, Ana Luísa De Sousa-Coelho, Marco A Campinho, Mónica T Fernandes
Förderung
- Fundação para a Ciência e Tecnologia
- PhD fellowship
Zitieren
APA
Correia, C. D., Calado, S. M., Matos, A., Esteves, F., De Sousa-Coelho, A. L., Campinho, M. A., & Fernandes, M. T. (2025). Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models. Cells. https://doi.org/10.3390/cells14040292
Vancouver
Correia CD, Calado SM, Matos A, Esteves F, De Sousa-Coelho AL, Campinho MA, et al. Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models. Cells. 2025. doi:10.3390/cells14040292
BibTeX
@article{Correia2025,
author = {Correia, Cátia D and Calado, Sofia M and Matos, Alexandra and Esteves, Filipa and De Sousa-Coelho, Ana Luísa and Campinho, Marco A and Fernandes, Mónica T},
title = {Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14040292}
}
EUVIMED